More on ACAD
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Revenues | |
| Collaborative revenues | 5.27M |
| Operating expenses | |
| Research and development (includes stock-based compensation of $134, $150, $255, and $379, respectively) | 25.81M |
| General and administrative (includes stock-based compensation of $279, $223, $534, and $475, respectively) | |
| Total operating expenses | |
| Loss from operations | -72.4M |
| Interest income, net | |
| Net loss | -71.61M |
| Net loss per common share, basic and diluted | -0.61 |
| Weighted average common shares outstanding, basic and diluted | |
Entities mentioned with ACAD
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Needham & Company | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- Pre Market Movers | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
